Abigail Beaney

BioVie's stock crashed after the biotech released data from its Phase IIb Parkinson's disease trial that used a unique composite measure.

Arena International’s OCT and CTS China will include sessions on how the country is continuing to cement itself globally.

As China's powerhouse status grows even bigger in the clinical trial space, industry leaders are set to come together to discuss how the country will continue to grow.

In the absence of a vaccine candidate for the Bundibugyo, panellists agreed to investigate Ervebo against the strain.

Despite the miss, a subgroup of patients with more severe disease showed more meaningful benefit - data Tenax plans to submit to the FDA and EMA.

Tenax Therapeutics' stock dropped by nearly 90% after a Phase III trial of its oral therapy for pulmonary hypertension associated with heart failure with preserved ejection fraction (PH-HFpEF) failed to meet its endpoints.

The PsA data follows a successful readout for MoonLake’s drug in HS earlier in 2026.

MoonLake Immunotherapeutics' sonelokimab has shown benefit in patients with psoriatic arthritis (PsA), with a Phase III trial meeting its primary endpoint.

The CRISPR therapy, SNIPR001, was administered to the patient who had developed E. Coli following a single-patient emergency IND.

A patient who developed multidrug-resistant E. coli following a transplant has recovered following treatment with an investigational clustered regularly interspaced short palindromic repeats (CRISPR) gene therapy.